Product NDC: | 49884-937 |
Proprietary Name: | QUESTRAN |
Non Proprietary Name: | Cholestyramine |
Active Ingredient(s): | 4 g/5g & nbsp; Cholestyramine |
Administration Route(s): | ORAL |
Dosage Form(s): | POWDER, FOR SUSPENSION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49884-937 |
Labeler Name: | Par Pharmaceutical Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077203 |
Marketing Category: | ANDA |
Start Marketing Date: | 20050915 |
Package NDC: | 49884-937-65 |
Package Description: | 60 PACKET in 1 CARTON (49884-937-65) > 5 g in 1 PACKET (49884-937-63) |
NDC Code | 49884-937-65 |
Proprietary Name | QUESTRAN |
Package Description | 60 PACKET in 1 CARTON (49884-937-65) > 5 g in 1 PACKET (49884-937-63) |
Product NDC | 49884-937 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Cholestyramine |
Dosage Form Name | POWDER, FOR SUSPENSION |
Route Name | ORAL |
Start Marketing Date | 20050915 |
Marketing Category Name | ANDA |
Labeler Name | Par Pharmaceutical Inc. |
Substance Name | CHOLESTYRAMINE |
Strength Number | 4 |
Strength Unit | g/5g |
Pharmaceutical Classes | Bile Acid Sequestrant [EPC],Bile-acid Binding Activity [MoA] |